Diagnostic Lab Claim Denials Jumped 40% in 2025, New XiFin Research Report Finds
XiFin’s 2026 Payor Denial Impact Report finds that lab denial rates rose 40%. Empower AI Appeals makes previously cost-prohibitive appeals practical to pursue while reducing manual appeal preparation time by up to 90%. Key findings of the 2026 Payor Denial Impact Report Denials rose…